Has Sujal Rangwalla received payments from drug or device companies?

Yes. Drug and device makers reported $3,258 in general payments to Sujal Rangwalla across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sujal Rangwalla did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sujal Rangwalla come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sujal Rangwalla

Pediatric Gastroenterology · Austin, TXNPI 1144354440

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 30.5% of the total.

$3,258in general payments, 2019–2025

Across 116 payments — averaging $28.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$994
Takeda Pharmaceuticals U.S.A., Inc.$428
Sanofi$300
Mirum Pharmaceuticals, Inc.$219
Ipsen Biopharmaceuticals, Inc$209
Baxter Healthcare$180
plus $930 from 17 others

What the payments were for

Food & beverage$3,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	41	$994
Takeda Pharmaceuticals U.S.A., Inc.	17	$428
Sanofi	12	$300
Mirum Pharmaceuticals, Inc.	5	$219
Ipsen Biopharmaceuticals, Inc	4	$209
Baxter Healthcare	2	$180
Alcresta Therapeutics, Inc.	2	$155
Chiesi USA, Inc.	1	$107
Nestle Healthcare Nutrition Inc.	4	$87
Regeneron Healthcare Solutions, Inc.	3	$79
Travere Therapeutics, Inc.	6	$79
Philips North America LLC	1	$72
QOL Medical, LLC	3	$64
AstraZeneca	2	$50
Azurity Pharmaceuticals, Inc.	3	$49
Amgen	2	$33
Aimmune Therapeutics, Inc.	2	$32
Mylan Specialty L.p.	1	$27
Mauna Kea Technologies, Inc.	1	$24
Pharming Healthcare, Inc.	1	$21
Rhythm Pharmaceuticals, Inc.	1	$18
Medtronic	1	$16
Applied Medical Technology Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Livmarli$139
Bylvay$136
Hillrom - Monarch Airway Clearance System$126
RELIZORB$119
PERTZYE$107
Humira$107

How this compares

$3,258 in reported general payments places this provider in the 80th percentile of 159 pediatric gastroenterology providers in Texas.

See all pediatric gastroenterology providers in Texas →

Other pediatric gastroenterology in Austin

Dennis HeintzAustin$15K
Anees SiddiquiAustin$6K
Sandra Camacho GomezAustin$2K
Robert ZwienerAustin$2K
Chantal Lucia CasadonteAustin$2K
Trevor LabordaAustin$2K
Bharani ChallaAustin$1K
Naveen MittalDallas$182K
Wenly RuanHouston$155K
Amal AqulDallas$99K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →